We have located links that may give you full text access.
CASE REPORTS
JOURNAL ARTICLE
Treatment of unusual vascular lesions: usefulness of sclerotherapy in lymphangioma circumscriptum and acquired digital arteriovenous malformation.
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [et Al.] 2005 November
BACKGROUND: Sclerotherapy is used in venous malformations and hemangiomas, as well as chronic venous insufficiency and hemorrhoids.
OBJECTIVE: To report on the usefulness of sclerotherapy in the treatment of unusual vascular lesions, such as lymphangioma circumscriptum and acquired digital arteriovenous malformation.
METHODS: Two unusual cases were treated with a sclerosant, sodium tetradecyl sulfate.
RESULTS: The patients were almost cleared with several treatments of sclerotherapy.
CONCLUSION: Sclerotherapy can be recommended as an effective treatment method for unusual vascular lesions, such as lymphangioma circumscriptum and acquired digital arteriovenous malformation.
OBJECTIVE: To report on the usefulness of sclerotherapy in the treatment of unusual vascular lesions, such as lymphangioma circumscriptum and acquired digital arteriovenous malformation.
METHODS: Two unusual cases were treated with a sclerosant, sodium tetradecyl sulfate.
RESULTS: The patients were almost cleared with several treatments of sclerotherapy.
CONCLUSION: Sclerotherapy can be recommended as an effective treatment method for unusual vascular lesions, such as lymphangioma circumscriptum and acquired digital arteriovenous malformation.
Full text links
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app